+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Contract Research Outsourcing - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 453 Pages
  • October 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 347964

Global Contract Research Outsourcing Market to Reach $72.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Contract Research Outsourcing estimated at US$44.9 Billion in the year 2020, is projected to reach a revised size of US$72.1 Billion by 2027, growing at a CAGR of 7% over the period 2020-2027. Clinical, one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$48.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Discovery segment is readjusted to a revised 6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $18.1 Billion, While China is Forecast to Grow at 9.3% CAGR

The Contract Research Outsourcing market in the U.S. is estimated at US$18.1 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2027 trailing a CAGR of 9.3% over the period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.1% and 6.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Pre-Clinical Segment to Record 6.8% CAGR

In the global Pre-Clinical segment, USA, Canada, Japan, China and Europe will drive the 6.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.3 Billion in the year 2020 will reach a projected size of US$8.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 152 Featured)

  • Albany Molecular Research, Inc.
  • Charles River Laboratories International, Inc.
  • Covance Clinical Biotech
  • ICON plc
  • IQVIA Inc
  • Jubilant Biosys Ltd.
  • Laboratory Corporation of America® Holdings
  • Olon Ricerca Bioscience
  • PAREXEL International Corp.
  • Pharmaceutical Product Development, LLC.
  • Pharmaron
  • PRA Health Sciences, Inc.
  • Sygnature Discovery Limited
  • Syneos Health
  • SynteractHCR
  • WuXi AppTec

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to a digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Contract Research Outsourcing

What is the estimated value of the Global Market for Contract Research Outsourcing?

The Global Market for Contract Research Outsourcing was estimated to be valued at $44.9 Billion in 2020.

What is the growth rate of the Global Market for Contract Research Outsourcing?

The growth rate of the Global Market for Contract Research Outsourcing is 7.0%, with an estimated value of $72.1 Billion by 2027.

What is the forecasted size of the Global Market for Contract Research Outsourcing?

The Global Market for Contract Research Outsourcing is estimated to be worth $72.1 Billion by 2027.

Who are the key companies in the Global Market for Contract Research Outsourcing?

Key companies in the Global Market for Contract Research Outsourcing include Albany Molecular Research, Inc., Charles River Laboratories International, Inc., Covance Clinical Biotech, ICON plc, IQVIA Inc, Jubilant Biosys Ltd., Laboratory Corporation of America® Holdings, Olon Ricerca Bioscience and Pharmaceutical Product Development, LLC..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • COVID-19 Delivers Mixed Results for Pharmaceutical Research Outsourcing Industry
  • Players Focus on Collaborative Approach
  • Optimism Reigns in Latter Part of 2020
  • COVID-19 and Implications for Drug Development Regulations & Processes
  • Opportunities in COVID-19 Programs
  • Parallel Gains for Development & Manufacturing
  • Contract Research Outsourcing - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Contract Research Outsourcing: An Introduction
  • Key Service Markets
  • Market Dynamics
  • Key Therapeutic Areas of Clinical Trial Research
  • Global Clinical Trial Services Market by Therapeutic Area: 2019
  • Top 6 Therapeutic Categories by Number of R&D Products in 2020
  • Cost Savings Hold Relevance
  • Product Innovations & Enhanced Speed
  • Access to Expertise & Sophisticated Technology
  • Outlook
  • Regional Market Analysis
  • Future Model of CRO
  • COMPETITIVE SCENARIO
  • CRO: A Highly Fragmented Market
  • Leading Players in the Global Contract Research Outsourcing Market (2019): Percentage Breakdown of Revenues by Player
  • Partnership Models Pay Returns
  • Strategies and Tactical Programs
  • Large CROs Seek the Inorganic Growth Route
  • Key Opportunities for CROs
  • Technological Superiority: An Advantage
  • Consolidation to Gain Pace
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Uptrend in Advanced Medicine Concepts Favors Growth
  • Drug Developers Bet on CROs to Sail through Challenging Aspects
  • Pharmaceutical & Biopharmaceutical Firms Target Outsourcing
  • Gene Therapy Offers Exciting Opportunities for CROs
  • COVID-19 Creates a Pause in Gene Therapy Market Growth
  • Gene Therapy Set to Witness Rapid Growth Post COVID-19
  • Global Gene Therapy Market in US$ Million for Years 2020, 2022, 2024, 2026
  • Increasing Significance of Biologic Drugs Supports Market Demand
  • Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025
  • COVID-19 Drives Strong Gains for Biologics Activity
  • Opportunities Rife in Early Stage Drug Development
  • Notable Trends in Pharma/Biopharma R&D Impacting CROs
  • Advances in Digital/Technology and its Impact on Clinical Development
  • Significant Strides Taken in the Sphere of Current Clinical Research
  • Data Quality Oversight (DQO) Undergoes Change
  • Pharmacovigilance Set to Grow
  • Artificial Intelligence and Machine Learning Gain Interest
  • Orphan Drugs to the Fore
  • CROs Adapt New Technologies to See More Business in Future
  • Streamlining Development of Novel Trial Designs
  • Industry Witnesses Increased Spend on R&D Outsourcing
  • Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
  • Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2019
  • Focus on Enhancing Site Selection and Patient Enrollment
  • CROs Enter into Alliances to Improve Efficiencies
  • Adoption of Digital Technologies Gains Pace
  • Toxicology Services Gain Notable Attention
  • Pharma Companies Enter into Licensing Agreements with Biotech Companies for New Drug Discovery
  • Pharmaceutical & Biopharmaceutical Trends to Support CRO Penetration
  • Global Biopharma % R&D Outsourcing (2014-2022)
  • New FDA Drug Approvals (2010-2016): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals
  • eClinical Solutions Gain Traction
  • Other Noteworthy Market Trends
  • Challenges Faced by Contract Research Organizations
  • Surging Global Population Offers Increased Growth Opportunities
  • World Population (in Thousands) by Geographic Region for the Years 2018, 2025, 2040, 2050
  • Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
  • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • World Diabetes and Population Statistics (2019, 2030 & 2045)
  • Increasing Healthcare Expenditure and Demand for Generics to Drive Growth
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Exhibit Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2012, 2021 & 2027
  • Table 4: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
  • Table 7: World Recent Past, Current & Future Analysis for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
  • Table 10: World Recent Past, Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
  • Table 13: World Recent Past, Current & Future Analysis for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
  • Table 16: World Recent Past, Current & Future Analysis for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
  • Table 19: World Recent Past, Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 20: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 21: World 15-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
  • Table 22: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 23: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 24: World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Market Overview
  • COVID-19 Pandemic: Mixed Bag of Opportunities for CROs
  • Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings
  • Trial Services Witness Strong Demand
  • High Demand for Data Management Services
  • Risk-based Monitoring Catches Pace
  • Market Analytics
CANADA
JAPAN
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
CHINA
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Market Overview
EUROPE
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Market Overview
  • Amid Pandemic, CRO Industry in Europe Gears Up for Broad-based Amendments
  • Providers Expand Services in Downstream Drug Development
  • Market Analytics
FRANCE
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
GERMANY
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
ITALY
UNITED KINGDOM
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
  • Market Overview
  • Asia-Pacific to Push Up Volume Share in CRO Market
  • R&D Outsourcing in Life Sciences on Rise
  • Market Analytics
INDIA
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
  • Indian CROs Seek Opportunities
REST OF ASIA-PACIFIC
  • Market Overview
  • Australia: Popular Destination for Early Phase Clinical Trials
  • Market Analytics
LATIN AMERICA
  • Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
REST OF WORLD
IV. COMPETITION
  • Total Companies Profiled: 152

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Albany Molecular Research, Inc.
  • Charles River Laboratories International, Inc.
  • Covance Clinical Biotech
  • ICON plc
  • IQVIA Inc
  • Jubilant Biosys Ltd.
  • Laboratory Corporation of America® Holdings
  • Olon Ricerca Bioscience
  • PAREXEL International Corp.
  • Pharmaceutical Product Development, LLC.
  • Pharmaron
  • PRA Health Sciences, Inc.
  • Sygnature Discovery Limited
  • Syneos Health
  • SynteractHCR
  • WuXi AppTec